According to Onconova Therapeutics's latest financial reports the company has C$23.63 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | C$52.59 M | -25.07% |
2021-12-31 | C$70.18 M | 189.32% |
2020-12-31 | C$24.25 M | -18.27% |
2019-12-31 | C$29.68 M | 28.4% |
2018-12-31 | C$23.11 M | 356.92% |
2017-12-31 | C$5.05 M | -82.45% |
2016-12-31 | C$28.82 M | 4.95% |
2015-12-31 | C$27.46 M | -45.7% |
2014-12-31 | C$50.57 M | -52.49% |
2013-12-31 | C$0.10 B | 31.31% |
2012-12-31 | C$81.07 M | 2837.69% |
2011-12-31 | C$2.75 M |